|
Antithrombin III (AT-III) is a blood protein that inhibits or stops the clotting factors
in blood. Approximately 75% of the body's plasma coagulation inhibitory activity is derived
from AT-III. AT-III deficiency is a rare inherited or spontaneously occurring condition
that affects one in every 2,000 to 5,000 males and females worldwide. Individuals with
the condition lack the AT-III protein and spontaneous clotting can occur as a result of
normal, daily activity. A doctor or healthcare provider prescribes Antithrombin III.
Please note: Country-specific regulatory requirements limit the information we can provide about our products. In addition,
approved indications (uses), product labels, and packaging for a prescription drug may differ between
countries. Please refer to the prescribing information provided for your country of residence.
Thrombate III®, Antithrombin III (Human) reaches patients around the world, including those in:
|